J. C. López

发表

Similar antiviral efficacy and tolerability between efavirenz and lopinavir/ritonavir, administered with abacavir/lamivudine (Kivexa), in antiretroviral-naïve patients: a 48-week, multicentre, randomized study (Lake Study).

B. Clotet, E. Negredo, R. Lopez-Blazquez, 2010, Antiviral research.

Effects of Hepatitis C Virus (HCV) Eradication on Bone Mineral Density in Human Immunodeficiency Virus/HCV-Coinfected Patients

M. Salavert, J. Navarro, A. Curran, 2020, Clinical Infectious Diseases.

Inflammatory reactions in progressive multifocal leukoencephalopathy after highly active antiretroviral therapy.

J. Cosín, C. Lacruz, J. Berenguer, 2001, AIDS.

Diagnosis of advanced fibrosis in HIV and hepatitis C virus‐coinfected patients via a new noninvasive index: the HGM‐3 index

M. Muñoz-Fernandez, J. Cosín, P. Catalán, 2010, HIV medicine.

Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus‐coinfected patients and correlation with noninvasive serum markers

J. Cosín, J. Arribas, J. Cosín, 2010, Journal of viral hepatitis.

Simplification to dual therapy (atazanavir/ritonavir + lamivudine) versus standard triple therapy [atazanavir/ritonavir + two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)

B. Clotet, M. Odriozola, J. Olalla, 2017, The Journal of antimicrobial chemotherapy.

IL28RA polymorphism (rs10903035) is associated with insulin resistance in HIV/HCV‐coinfected patients

D. Micheloud, S. Resino, M. Jiménez-Sousa, 2014, Journal of viral hepatitis.

Association of torque teno virus (TTV) and torque teno mini virus (TTMV) with liver disease among patients coinfected with human immunodeficiency virus and hepatitis C virus

M. Muñoz-Fernandez, J. Cosín, E. Álvarez, 2012, European Journal of Clinical Microbiology & Infectious Diseases.

Identification of liver fibrosis in HIV/HCV‐coinfected patients using a simple predictive model based on routine laboratory data

F. Álvarez, J. Cosín, P. Catalán, 2007, Journal of viral hepatitis.

Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR

I. Martínez, M. Salavert, E. Ribera, 2019, Scientific Reports.

IL28RA polymorphism is associated with early hepatitis C virus (HCV) treatment failure in human immunodeficiency virus‐/HCV‐coinfected patients

V. Soriano, J. Cosín, N. Rallón, 2013, Journal of viral hepatitis.

Discontinuation of secondary anti-leishmania prophylaxis in HIV-infected patients who have responded to highly active antiretroviral therapy.

J. Cosín, J. Berenguer, B. Padilla, 2000, AIDS.

Use of transient elastography (FibroScan®) for the noninvasive assessment of portal hypertension in HIV/HCV‐coinfected patients

J. Cosín, C. Ripoll, R. Bañares, 2011, Journal of viral hepatitis.

Potentially inappropriate medications in older adults living with HIV.

C. Marzolini, Carlos Badenes-Olmedo, J. Bellón, 2020, HIV medicine.

Association of torque teno virus (TTV) and torque teno mini virus (TTMV) with liver disease among patients coinfected with human immunodeficiency virus and hepatitis C virus

J. Cosín, P. Catalán, E. Álvarez, 2013, European Journal of Clinical Microbiology & Infectious Diseases.

Neurocognitive safety after 96 weeks on dual therapy with atazanavir/ritonavir plus lamivudine: results of the neurocognitive substudy of the SALT randomized clinical trial

J. De La Torre, J. Prada, S. Reus, 2018, The Journal of antimicrobial chemotherapy.